To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation
Clinical trial NCT05674981 · COMPLETED
Trial details
- NCT number
- NCT05674981
- Sponsor
- GenMont Biotech Incorporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2025-04-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.